Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Feb 27, 2024; 16(2): 396-408
Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.396
Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.396
Table 3 Comparison of toxicity between the obvious response group and the poor response group
| System | Total, n = 230 (%) | Obvious response, n = 95 (%) | Poor response, n = 135 (%) | χ2 | P value |
| Gastrointestinal | 91 (39.57) | 41 (43.16) | 50 (37.04) | 0.874 | 0.350 |
| Hematological | 169 (73.48) | 71 (74.74) | 98 (72.59) | 0.132 | 0.717 |
| Neurological | 39 (16.96) | 19 (20.00) | 20 (14.81) | 1.065 | 0.302 |
| Cardiac | 1 (0.43) | 1 (1.05) | 0 | 1.385 | 0.239 |
- Citation: Liu B, Xu YJ, Chu FR, Sun G, Zhao GD, Wang SZ. Development of a clinical nomogram for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer. World J Gastrointest Surg 2024; 16(2): 396-408
- URL: https://www.wjgnet.com/1948-9366/full/v16/i2/396.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i2.396